These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9345469)

  • 1. Case finding for epidemiological surveys of multiple sclerosis in United States communities.
    Nelson LM; Anderson DW
    Mult Scler; 1995 Apr; 1(1):48-55. PubMed ID: 9345469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Projection of the number of multiple sclerosis patients in Germany].
    Hein T; Hopfenmüller W
    Nervenarzt; 2000 Apr; 71(4):288-94. PubMed ID: 10795096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capture-recapture as a potentially useful procedure for assessing prevalence of multiple sclerosis: methodologic exercise using Portuguese data.
    de Sá J; Alcalde-Cabero E; Almazán-Isla J; Sempere A; de Pedro-Cuesta J
    Neuroepidemiology; 2012; 38(4):209-16. PubMed ID: 22555496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
    Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
    Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.
    Poskanzer DC; Prenney LB; Sheridan JL; Kondy JY
    J Epidemiol Community Health; 1980 Dec; 34(4):229-39. PubMed ID: 7241022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of multiple sclerosis in 3 US communities.
    Noonan CW; Williamson DM; Henry JP; Indian R; Lynch SG; Neuberger JS; Schiffer R; Trottier J; Wagner L; Marrie RA
    Prev Chronic Dis; 2010 Jan; 7(1):A12. PubMed ID: 20040227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher than expected prevalence of multiple sclerosis in northern Colorado: dependence on methodologic issues.
    Nelson LM; Hamman RF; Thompson DS; Baum HM; Boteler DL; Burks JS; Franklin GM
    Neuroepidemiology; 1986; 5(1):17-28. PubMed ID: 3489193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perceptions of multiple sclerosis-related care: comparisons by practice specialty of principal care physician.
    Buchanan RJ; Kaufman M; Zhu L; James W
    NeuroRehabilitation; 2008; 23(3):267-72. PubMed ID: 18560144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised estimate of the prevalence of multiple sclerosis in the United States.
    Anderson DW; Ellenberg JH; Leventhal CM; Reingold SC; Rodriguez M; Silberberg DH
    Ann Neurol; 1992 Mar; 31(3):333-6. PubMed ID: 1637140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics of a national register of people with multiple sclerosis (MS): a comparison between the ARMS (Action for Research into Multiple Sclerosis) register and 10 British MS populations.
    Monks J; Robinson I
    J Epidemiol Community Health; 1989 Jun; 43(2):179-86. PubMed ID: 2592908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
    Buchanan RJ; Seibert AL; Crudden A; Minden S
    J Soc Work Disabil Rehabil; 2013; 12(4):237-55. PubMed ID: 24224971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-finding for MS prevalence studies in small communities requires a community-based approach.
    Cowen JB; Sjostrom BF; Doughty AS; Schiffer RB
    Neuroepidemiology; 2007; 28(4):246-52. PubMed ID: 17878739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method.
    El Adssi H; Debouverie M; Guillemin F;
    Mult Scler; 2012 Sep; 18(9):1244-50. PubMed ID: 22354740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment.
    Wittie M; Nelson LM; Usher S; Ward K; Benatar M
    Neuroepidemiology; 2013; 40(2):133-41. PubMed ID: 23095852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis prevalence and mortality in Allegheny County for 1965 and 1966.
    Ray R; Balmuth M; Drew FL
    Am J Public Health Nations Health; 1970 Dec; 60(12):2321-30. PubMed ID: 5530417
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis: managing patients in primary care.
    Maloni HW
    Nurse Pract; 2013 Apr; 38(4):24-35; quiz 35-6. PubMed ID: 23454903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of multiple sclerosis in British Columbia.
    Sweeney VP; Sadovnick AD; Brandejs V
    Can J Neurol Sci; 1986 Feb; 13(1):47-51. PubMed ID: 3955451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis.
    Charles J; Valenti L; Britt H
    Aust Fam Physician; 2011 Dec; 40(12):947. PubMed ID: 22256380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of multiple sclerosis in communities concerned about environmental exposures.
    Williamson DM
    J Womens Health (Larchmt); 2006 Sep; 15(7):810-4. PubMed ID: 16999635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis prevalence and possible lead exposure.
    Turabelidze G; Schootman M; Zhu BP; Malone JL; Horowitz S; Weidinger J; Williamson D; Simoes E
    J Neurol Sci; 2008 Jun; 269(1-2):158-62. PubMed ID: 18282582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.